Sunshine Pictures Ltd Share Price Today

Sunshine Pictures Ltd. Share Price

Overview

Sunshine Pictures Ltd. share price is currently ₹435.52, up by ₹1.50 (0.35%) from its previous closing price of ₹434.02. The share price has gained 0.6% over the past month and gained 0.6% over the past year. The stock's 52-week low and high are ₹360.68 and ₹471.61, respectively. Sunshine Pictures Ltd. has a market capitalisation of ₹ 1,340.00 Cr. The share price was last updated on 04 Sep 2026, 03:56 PM IST.

Shashank Gupta

28 Aug • 5:20 PM · SEBI-Registered Analyst

Nestlé India Invests in Captive Solar Power

NESTLEIND

Nestlé India has agreed to acquire a 26% equity stake in Radiance KA Sunshine Seven Private Limited for ₹7.61 crore to support the establishment of a captive renewable energy power arrangement for one of its manufacturing facilities. Radiance KA operates a solar power plant in Karnataka with a capacity of 17.5 MW AC / 26.25 MWp DC. The investment is intended to help Nestlé increase the share of renewable energy in its operations while meeting the regulatory requirements applicable to captive power users. In my view, the development is strategically positive even though the investment amount is relatively small for Nestlé India. Captive renewable power can potentially provide greater visibility over long-term energy sourcing and reduce exposure to fluctuations in conventional power costs, while also supporting the company's sustainability objectives. Since the stake is structured to enable captive consumption rather than as a purely financial investment, the key benefit will depend on the economics and reliability of the power supplied to the manufacturing facility. Investors should monitor whether Nestlé expands similar renewable-energy arrangements across other facilities and the resulting impact on operating costs. Overall, the investment reflects a positive step towards improving renewable-energy integration and potentially strengthening long-term energy-cost management.

Ketan Mittal (SEBI RA)

21 Aug • 11:01 AM · SEBI-Registered Analyst

Sunshine Pictures IPO

Bidding for the initial public offering of film maker Vipul Shah and wife Shefali Shah-promoted company Sunshine Pictures Ltd ended on 20 August 2026. The public issue received a strong response from investors. According to Sunshine Pictures IPO subscription status, the book-building issue was subscribed to around 105 times its size. This led to a bullish grey-market sentiment. According to market observers, Sunshine Pictures' IPO GMP (Grey Market Premium) today is ₹75, signalling more than 20% listing pop.

Naveen Kumar

17 Aug • 4:56 PM · SEBI-Registered Analyst

Sunshine Pictures IPO

Does stock fall in these catagories?: Strong Management Aligned Interest: Promoters are retaining a 75% stake post-IPO, signaling high confidence and skin-in-the-game. Content Library & IP Assets: The company owns long-tail revenue rights music and social media exploitation from its past successful films, providing a base layer of recurring income. Experience & Track Record: Proven ability to produce high-impact, controversial cinema e.g., The Kerala Story impact which creates "revenge viewing" and viral marketing, often outperforming traditional content. Low Debt: The company operates with minimal debt; IPO funds are primarily aimed at replacing high-cost working capital loans. Key Risks Discussed: Deteriorating Financials: Revenue has been in a consistent downward trend 133 Cr → 100 Cr → 74 Cr, indicating a struggle to maintain consistent output. Hit-or-Miss Business Model: The company’s financial success is binary—entirely dependent on whether individual movies/shows become viral hits or controversies. Overvaluation: The IPO asks for a valuation of ₹1100 Cr, which is not supported by current earnings or physical asset depth. Trade Receivables: While not yet marked as "doubtful," there is a notable amount of money stuck in receivables, common in the media industry. Execution Risk: Shifting from consolidated to standalone financials creates opacity in understanding historical performance compared to future projections.

Ketan Mittal (SEBI RA)

17 Aug • 1:16 PM · SEBI-Registered Analyst

Sunshine Pictures IPO

Sunshine Pictures IPO is set to open for public subscription on Tuesday, 18 August. The book build issue is hitting the primary market at a time when market sentiment is weak due to persistent uncertainty over US-Iran talks and crude oil price volatility. Sunshine Pictures is a production house engaged in creating, developing, producing, marketing and distributing films, TV serials, and web series. Meanwhile, grey market trends suggest investors are optimistic about the issue, as the latest grey market premium (GMP) signals the stock could list at a decent premium.

RAJIV GUPTA (SEBI RA)

24 Jul • 5:30 PM · SEBI-Registered Analyst

Performance Highlights: Q1 FY27 - Dr Lal Pathlabs Ltd

Code BSE: 539524 NSE:

LALPATHLAB

Revenue increased by 19.1% in Q1 FY27 a) EBITDA for Q1 FY27 increased by 28.7% with a margin of 31.0% b) PAT for Q1 FY27 is Rs 170 Cr. with a margin for of 21.4% c) Interim Dividend of 50% i.e. Rs. 5 per share. d) Cash and Cash equivalents as on 30th June 2026 is Rs. 1,693 Cr. e)Acquisition of 80% equity stake in Sunshine Healthcare Limited, Ghana engaged in diagnostic business for a consideration not exceeding GHS 45.6 million.

Amit Malviya

29 Jun • 10:32 AM · SEBI-Registered Analyst

India’s pharma sector is buzzing today (29 June 2026) with strong stock gains

India’s pharma sector is buzzing today (29 June 2026) with strong stock gains led by

DRREDDY

AJANTPHARM

, and IPCA Labs, while Alkem Labs advanced its overseas acquisition. Strides Pharma also announced a ₹100 crore divestment, and new government-backed vaccine research for seniors is making headlines. 💊 Key Pharma Developments – 29 June 2026 📈 Stock Market & Sector Performance Pharma stocks rose up to 5%, outperforming other sectors. Top gainers: Dr. Reddy’s Laboratories Ajanta Pharma IPCA Laboratories Indices: Nifty Pharma & Healthcare outperformed. Nifty IT was the biggest laggard. 🏥 Corporate Moves Alkem Labs’ subsidiary (Alkem Medtech) completed a supplementary agreement to acquire Occlutech Holding, securing 51–55% equity stake. This strengthens its global medtech footprint. Strides Pharma Science Ltd divested majority stake in Pivot Path for ₹100 crore to investors led by Ascent Capital and Vintage. 🧪 Policy & Healthcare Updates AIIMS-led study: India’s first evidence that a government-funded annual flu vaccine for seniors could reduce illness and deaths at affordable cost. This could pave the way for a national immunization program for the elderly. Health Ministry is proposing faster licensing timelines for medical device manufacturers, aiming to streamline approvals and boost innovation. Centre notified Drugs (Seventh Amendment) Rules, 2026, tightening regulatory frameworks for drug approvals. 🌍 Global & Strategic Moves Zydus Lifesciences signed a JV with Sunshine Healthcare to expand operations. Merck KGaA announced a $11.3 billion acquisition of Bio-Techne, signaling consolidation in global life sciences.

Sunshine Pictures Ltd. Share Price

Overview

Market Data

Open Price

Prev. Close

Day Low

Day High

52 Week Low

52 Week High

Fundamentals

Quick Bite

Price To Earnings Ratio

Sector PE

PB Ratio

Sector PB

EPS

Dividend Yield

Today's Volume

5 Day Avg. Volume

PEG Ratio

Market Cap.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Mutual Fund Ownership

About Sunshine Pictures Ltd. 👋

Expert Opinions

News & Events

Frequently Asked Questions

What is the share price of Sunshine Pictures Ltd.?

What is the market cap of Sunshine Pictures Ltd.?

Should I buy Sunshine Pictures Ltd. stock now?

What is the 52 week high and low of Sunshine Pictures Ltd.?

Is the Sunshine Pictures Ltd. stock good to buy?

Is Sunshine Pictures Ltd. a good buy for the long term?

Is Sunshine Pictures Ltd. overvalued or undervalued?

What is the PE and PB ratio of Sunshine Pictures Ltd.?